TRIM71 and embryonal carcinoma: Additionally, we used the human GCT-derived non-seminoma cell line NCCIT to generate TRIM71 mutations via CRISPR/Cas9 in order to investigate the role of TRIM71 in the proliferation of pluripotent embryonal carcinoma cells.